Quick Answer
Altamira Therapeutics Ltd. reported Total Assets of $8.65 million for fiscal year 2024.
Altamira Therapeutics Ltd. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2024 | $8.65M | -5.4% |
| 2023 | $9.14M | +34.2% |
| 2022 | $6.81M | -64.5% |
| 2021 | $19.17M | -7.8% |
| 2020 | $20.80M | +125.4% |
| 2019 | $9.23M | -6.6% |
| 2018 | $9.88M | -44.6% |
| 2017 | $17.83M | -50.0% |
| 2016 | $35.66M | — |
- Altamira Therapeutics Ltd. showed a decrease of -5.4% in Total Assets compared to the prior fiscal year.
- Over the 2016–2024 period, Altamira Therapeutics Ltd.’s total assets has declined by 75.7% (from $35.66 million to $8.65 million).
- The most recent figure is from Altamira Therapeutics Ltd.’s fiscal year 2024 report (Form 20-F), filed with the SEC on April 30, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: